Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Change in Acquisitions & Divestments (2023 - 2025)

Cytek Biosciences' Change in Acquisitions & Divestments history spans 3 years, with the latest figure at $76.1 million for Q4 2025.

  • For Q4 2025, Change in Acquisitions & Divestments rose 69.12% year-over-year to $76.1 million; the TTM value through Dec 2025 reached $292.2 million, up 49.85%, while the annual FY2025 figure was $292.2 million, 49.85% up from the prior year.
  • Change in Acquisitions & Divestments reached $76.1 million in Q4 2025 per CTKB's latest filing, down from $79.2 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $79.2 million in Q3 2025 to a low of $10.0 million in Q2 2023.
  • Average Change in Acquisitions & Divestments over 3 years is $56.3 million, with a median of $66.5 million recorded in 2025.
  • The largest YoY upside for Change in Acquisitions & Divestments was 300.0% in 2024 against a maximum downside of 44.12% in 2024.
  • A 3-year view of Change in Acquisitions & Divestments shows it stood at $54.0 million in 2023, then decreased by 16.67% to $45.0 million in 2024, then skyrocketed by 69.12% to $76.1 million in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Change in Acquisitions & Divestments are $76.1 million (Q4 2025), $79.2 million (Q3 2025), and $66.5 million (Q2 2025).